Literature DB >> 21354376

Endogenous epinephrine protects against obesity induced insulin resistance.

Michael G Ziegler1, Milos Milic, Ping Sun, Chih-Min Tang, Hamzeh Elayan, Xuping Bao, Wai Wilson Cheung, Daniel T O'Connor.   

Abstract

Epinephrine (E) is a hormone released from the adrenal medulla in response to low blood sugar and other stresses. E and related β2-adrenergic agonists are used to treat asthma, but a side effect is high blood sugar. C57BL/6 mice prone to overfeeding induced type II diabetes had the PNMT gene knocked out to prevent E synthesis. These E deficient mice were very similar to control animals on a 14% fat diet. On a 40.6% fat diet they gained 20 to 33% more weight than control animals and increased their blood glucose response to a glucose tolerance test because they became resistant to insulin. Although the short term effect of β2-agonists such as E is to raise blood glucose, some long acting β2-agonists improve muscle glucose uptake. Endogenous E protects against overfeeding induced diabetes. Since adrenal E release can be impaired with aging and diabetes, endogenous E may help prevent adult onset diabetes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354376      PMCID: PMC3111898          DOI: 10.1016/j.autneu.2011.01.009

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  17 in total

1.  A more sensitive and specific radioenzymatic assay for catecholamines.

Authors:  B Kennedy; M G Ziegler
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

Review 2.  Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.

Authors:  A M Sharma; T Pischon; S Hardt; I Kunz; F C Luft
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

3.  Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.

Authors:  S Jacob; K Rett; M Wicklmayr; B Agrawal; H J Augustin; G J Dietze
Journal:  J Hypertens       Date:  1996-04       Impact factor: 4.844

Review 4.  Human ageing and the sympathoadrenal system.

Authors:  D R Seals; M D Esler
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

5.  Improved insulin-stimulated glucose uptake and glycogen synthase activation in rat skeletal muscles after adrenaline infusion: role of glycogen content and PKB phosphorylation.

Authors:  J Jensen; J Ruzzin; E Jebens; E O Brennesvik; S Knardahl
Journal:  Acta Physiol Scand       Date:  2005-06

6.  Clenbuterol-induced insulin resistance in calves measured by hyperinsulinemic, euglycemic clamp technique.

Authors:  K Sternbauer; J Luthman; A Hänni; S O Jacobsson
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

Review 7.  Adrenaline: a physiological metabolic regulatory hormone in humans?

Authors:  P E Cryer
Journal:  Int J Obes Relat Metab Disord       Date:  1993-12

8.  Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels.

Authors:  B Kennedy; T D Bigby; M G Ziegler
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes.

Authors:  M Petrou; D G Wynne; K R Boheler; M H Yacoub
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

10.  Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse.

Authors:  Ann E Petro; Juliann Cotter; Dale A Cooper; John C Peters; Sarah J Surwit; Richard S Surwit
Journal:  Metabolism       Date:  2004-04       Impact factor: 8.694

View more
  9 in total

1.  Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout Mice.

Authors:  Gloria S Forkuo; Hosu Kim; Vaidehi J Thanawala; Nour Al-Sawalha; Daniel Valdez; Radhika Joshi; Sergio Parra; Tonio Pera; Patricia A Gonnella; Brian J Knoll; Julia K L Walker; Raymond B Penn; Richard A Bond
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

2.  Chronic β2 adrenergic agonist, but not exercise, improves glucose handling in older type 2 diabetic mice.

Authors:  Hamzeh Elayan; Milos Milic; Ping Sun; Munir Gharaibeh; Michael G Ziegler
Journal:  Cell Mol Neurobiol       Date:  2012-03-16       Impact factor: 5.046

Review 3.  The biochemical alterations underlying post-burn hypermetabolism.

Authors:  Christopher Auger; Osai Samadi; Marc G Jeschke
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-20       Impact factor: 5.187

Review 4.  Epinephrine and the metabolic syndrome.

Authors:  Michael G Ziegler; Hamzeh Elayan; Milos Milic; Ping Sun; Munir Gharaibeh
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

5.  High-fat diet promotes adrenaline production by visceral adipocytes.

Authors:  Andreia Gomes; Raquel Soares; Raquel Costa; Franca Marino; Marco Cosentino; Maria M Malagon; Laura Ribeiro
Journal:  Eur J Nutr       Date:  2019-04-22       Impact factor: 5.614

6.  β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model.

Authors:  Vaidehi J Thanawala; Gloria S Forkuo; Nour Al-Sawalha; Zoulikha Azzegagh; Long P Nguyen; Jason L Eriksen; Michael J Tuvim; Thomas W Lowder; Burton F Dickey; Brian J Knoll; Julia K L Walker; Richard A Bond
Journal:  Am J Respir Cell Mol Biol       Date:  2012-11-29       Impact factor: 6.914

7.  β-Blockers have differential effects on the murine asthma phenotype.

Authors:  V J Thanawala; D J Valdez; R Joshi; G S Forkuo; S Parra; B J Knoll; M Bouvier; P Leff; R A Bond
Journal:  Br J Pharmacol       Date:  2015-10-13       Impact factor: 8.739

8.  Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: In vitro and in vivo evidence.

Authors:  Qing-Xin Meng; Long Wen; Xin-Yu Chen; Hui-Ju Zhong
Journal:  Exp Ther Med       Date:  2013-04-03       Impact factor: 2.447

9.  Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours.

Authors:  Yaxin An; Manja Reimann; Jimmy Masjkur; Katharina Langton; Mirko Peitzsch; Timo Deutschbein; Martin Fassnacht; Natalie Rogowski-Lehmann; Felix Beuschlein; Stephanie Fliedner; Anthony Stell; Aleksander Prejbisz; Andrzej Januszewicz; Jacques Lenders; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Int J Obes (Lond)       Date:  2018-03-03       Impact factor: 5.095

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.